Skip to Content

Pfizer Says Inversion Deal Is Still On the Table

While Pfizer Inc.’s CEO acknowledged Tuesday that the U.S. Treasury Department’s recent crackdown on inversions has diminished the deal’s appeal, the drug maker has yet to rule out an acquisition that would lower its tax bill. New York-based Pfizer explored deals with AstraZeneca PLC and Actavis PLC this year that […]

Legislation

IRS Expects Tax-Refund Delays

The Internal Revenue Service is expecting a plethora of complications with the coming tax-filing season, IRS Commissioner John Koskinen said in an interview with the nonprofit publisher Tax Analysts that was published this week. Mr. Koskinen suggests, “The difference this year compared to the past is we are having to […]

IRS